Cenegermin, sold under the brand name Oxervate, also known as recombinant human nerve growth factor (rhNGF), is a recombinant form of human nerve growth...
6 KB (279 words) - 16:55, 6 June 2024
Anabasis product cenegermin, an eye drop containing recombinant human nerve growth factor, as a treatment for neurotrophic keratitis. Cenegermin was approved...
2 KB (202 words) - 09:25, 19 June 2024
Telisotuzumab vedotin IGF LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901...
68 KB (5,999 words) - 20:41, 31 August 2024
Telisotuzumab vedotin IGF LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901...
31 KB (3,430 words) - 05:24, 28 August 2024
Telisotuzumab vedotin IGF LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901...
121 KB (13,799 words) - 18:31, 13 September 2024
Telisotuzumab vedotin IGF LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901...
149 KB (15,717 words) - 11:49, 6 October 2024
Telisotuzumab vedotin IGF LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901...
93 KB (8,729 words) - 21:31, 30 September 2024
High Standard Manufacturing Company Sentinel, a brand name for the drug cenegermin Sentinel Offender Services, a for-profit probation company Sentinel Sound...
9 KB (1,090 words) - 15:44, 28 August 2024
Telisotuzumab vedotin IGF LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901...
17 KB (1,559 words) - 21:20, 27 September 2024
Telisotuzumab vedotin IGF LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901...
13 KB (1,177 words) - 02:19, 4 September 2024
Telisotuzumab vedotin IGF LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901...
20 KB (1,566 words) - 08:58, 12 August 2024
Telisotuzumab vedotin IGF LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901...
14 KB (1,671 words) - 23:17, 4 September 2024
Telisotuzumab vedotin IGF LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901...
21 KB (1,808 words) - 17:43, 7 September 2024
Telisotuzumab vedotin IGF LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901...
24 KB (1,890 words) - 16:21, 4 October 2024
Telisotuzumab vedotin IGF LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901...
35 KB (4,573 words) - 09:59, 28 August 2024
Telisotuzumab vedotin IGF LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901...
22 KB (1,787 words) - 05:10, 1 July 2024
Telisotuzumab vedotin IGF LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901...
16 KB (1,784 words) - 04:08, 6 January 2024
Telisotuzumab vedotin IGF LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901...
25 KB (2,086 words) - 02:24, 16 July 2024
Telisotuzumab vedotin IGF LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901...
17 KB (1,708 words) - 13:56, 21 July 2024
Telisotuzumab vedotin IGF LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901...
73 KB (6,455 words) - 18:49, 12 September 2024
Telisotuzumab vedotin IGF LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901...
10 KB (579 words) - 06:46, 26 June 2024
Telisotuzumab vedotin IGF LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901...
71 KB (6,702 words) - 05:32, 9 August 2024
Telisotuzumab vedotin IGF LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901...
46 KB (5,344 words) - 03:26, 11 August 2024
Telisotuzumab vedotin IGF LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901...
24 KB (2,872 words) - 06:27, 22 July 2024
Telisotuzumab vedotin IGF LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901...
39 KB (3,854 words) - 21:20, 3 September 2024
Telisotuzumab vedotin IGF LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901...
14 KB (1,689 words) - 01:31, 19 August 2024
Telisotuzumab vedotin IGF LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901...
16 KB (1,322 words) - 22:43, 12 September 2024
Telisotuzumab vedotin IGF LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901...
22 KB (1,994 words) - 04:41, 3 January 2024
Telisotuzumab vedotin IGF LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901...
10 KB (1,179 words) - 18:31, 8 August 2024
Telisotuzumab vedotin IGF LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901...
16 KB (1,122 words) - 03:21, 24 April 2024